260 related articles for article (PubMed ID: 8917039)
1. Mannitol, but not allopurinol, modulates changes in cerebral blood flow, intracranial pressure, and brain water content during pneumococcal meningitis in the rat.
Lorenzl S; Koedel U; Pfister HW
Crit Care Med; 1996 Nov; 24(11):1874-80. PubMed ID: 8917039
[TBL] [Abstract][Full Text] [Related]
2. Experimental pneumococcal meningitis: cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide.
Koedel U; Bernatowicz A; Paul R; Frei K; Fontana A; Pfister HW
Ann Neurol; 1995 Mar; 37(3):313-23. PubMed ID: 7535035
[TBL] [Abstract][Full Text] [Related]
3. Antioxidants attenuate microvascular changes in the early phase of experimental pneumococcal meningitis in rats.
Pfister HW; Koedel U; Lorenzl S; Tomasz A
Stroke; 1992 Dec; 23(12):1798-804. PubMed ID: 1448831
[TBL] [Abstract][Full Text] [Related]
4. Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis.
Koedel U; Bernatowicz A; Frei K; Fontana A; Pfister HW
J Immunol; 1996 Dec; 157(11):5185-91. PubMed ID: 8943431
[TBL] [Abstract][Full Text] [Related]
5. Effect of catalase on regional cerebral blood flow and brain edema during the early phase of experimental pneumococcal meningitis.
Pfister HW; Ködel U; Dirnagl U; Haberl RL; Ruckdeschel G; Einhäupl KM
J Infect Dis; 1992 Dec; 166(6):1442-5. PubMed ID: 1431262
[TBL] [Abstract][Full Text] [Related]
6. Effect of the bradykinin B2 receptor antagonist Hoe140 in experimental pneumococcal meningitis in the rat.
Lorenzl S; Ködel U; Frei K; Pfister HW
Eur J Pharmacol; 1996 Jul; 308(3):335-41. PubMed ID: 8858309
[TBL] [Abstract][Full Text] [Related]
7. Reduction of intracranial pressure by nimodipine in experimental pneumococcal meningitis.
Paul R; Koedel U; Pfister HW
Crit Care Med; 2000 Jul; 28(7):2552-6. PubMed ID: 10921593
[TBL] [Abstract][Full Text] [Related]
8. Methylprednisolone attenuates inflammation, increase of brain water content and intracranial pressure, but does not influence cerebral blood flow changes in experimental pneumococcal meningitis.
Koedel U; Pfister HW; Tomasz A
Brain Res; 1994 Apr; 644(1):25-31. PubMed ID: 8032946
[TBL] [Abstract][Full Text] [Related]
9. Fucoidin, a polysaccharide inhibiting leukocyte rolling, attenuates inflammatory responses in experimental pneumococcal meningitis in rats.
Angstwurm K; Weber JR; Segert A; Bürger W; Weih M; Freyer D; Einhäupl KM; Dirnagl U
Neurosci Lett; 1995 May; 191(1-2):1-4. PubMed ID: 7659273
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of a 21-aminosteroid during experimental pneumococcal meningitis.
Lorenzl S; Koedel U; Frei K; Bernatowicz A; Fontana A; Pfister HW
J Infect Dis; 1995 Jul; 172(1):113-8. PubMed ID: 7797900
[TBL] [Abstract][Full Text] [Related]
11. Is nitric oxide involved as a mediator of cerebrovascular changes in the early phase of experimental pneumococcal meningitis?
Haberl RL; Anneser F; Ködel U; Pfister HW
Neurol Res; 1994 Apr; 16(2):108-12. PubMed ID: 7913993
[TBL] [Abstract][Full Text] [Related]
12. Global brain water increases after experimental focal cerebral ischemia: effect of hypertonic saline.
Toung TJ; Hurn PD; Traystman RJ; Bhardwaj A
Crit Care Med; 2002 Mar; 30(3):644-9. PubMed ID: 11990928
[TBL] [Abstract][Full Text] [Related]
13. Endothelin B receptor-mediated increase of cerebral blood flow in experimental pneumococcal meningitis.
Koedel U; Lorenzl S; Gorriz C; Arendt RM; Pfister HW
J Cereb Blood Flow Metab; 1998 Jan; 18(1):67-74. PubMed ID: 9428307
[TBL] [Abstract][Full Text] [Related]
14. Tumour necrosis factor alpha induces only minor inflammatory changes in the central nervous system, but augments experimental meningitis.
Angstwurm K; Freyer D; Dirnagl U; Hanisch UK; Schumann RR; Einhäupl KM; Weber JR
Neuroscience; 1998 Sep; 86(2):627-34. PubMed ID: 9881875
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta 2 inhibits cerebrovascular changes and brain edema formation in the tumor necrosis factor alpha-independent early phase of experimental pneumococcal meningitis.
Pfister HW; Frei K; Ottnad B; Koedel U; Tomasz A; Fontana A
J Exp Med; 1992 Jul; 176(1):265-8. PubMed ID: 1613460
[TBL] [Abstract][Full Text] [Related]
16. Superior effect of hypertonic saline over mannitol to attenuate cerebral edema in a rabbit bacterial meningitis model.
Liu S; Li L; Luo Z; Wang M; She H; Yu X; Deng X; Huang F; Shang L; Jian C; Ji G; Yue S
Crit Care Med; 2011 Jun; 39(6):1467-73. PubMed ID: 21336112
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of the antioxidant N-acetyl-L-cysteine in pneumococcal meningitis in the rat.
Koedel U; Pfister HW
Neurosci Lett; 1997 Mar; 225(1):33-6. PubMed ID: 9143011
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine kinase inhibition reduces inflammation in the acute stage of experimental pneumococcal meningitis.
Angstwurm K; Hanisch UK; Gassemi T; Bille MB; Prinz M; Dirnagl U; Kettenmann H; Weber JR
Infect Immun; 2004 Jun; 72(6):3294-8. PubMed ID: 15155632
[TBL] [Abstract][Full Text] [Related]
19. Effects of early and late intravenous norepinephrine infusion on cerebral perfusion, microcirculation, brain-tissue oxygenation, and edema formation in brain-injured rats.
Kroppenstedt SN; Thomale UW; Griebenow M; Sakowitz OW; Schaser KD; Mayr PS; Unterberg AW; Stover JF
Crit Care Med; 2003 Aug; 31(8):2211-21. PubMed ID: 12973182
[TBL] [Abstract][Full Text] [Related]
20. Increases in lung and brain water following experimental stroke: effect of mannitol and hypertonic saline.
Toung TJ; Chang Y; Lin J; Bhardwaj A
Crit Care Med; 2005 Jan; 33(1):203-8; discussion 259-60. PubMed ID: 15644670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
